Remove Documentation Remove Drug Development Remove Research Laboratories
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

“Clearly the number one challenge in 2022, as mandated by the EU GMP Guidelines for the Manufacture of Sterile Medicinal Products Annex 1 1 , is the development of a Contamination Control Strategy (CCS),” Tony Cundell noted. He warned, “Implementation of a CCS will require more than writing documents.”.

Vaccines 128
article thumbnail

Panel Discussion: Evolving role of technology in enhancing manufacturing and quality assurance

Express Pharma

Panelists in this video: + Mr G Raghuraman, AGM-Quality, Bafna Pharmaceuticals (Moderator) + Mr Mathivanan Rajagopal, VP and Head R&D, Axxlent Pharma Science + Dr Mohan Lakshminarayan, Director – Operation & System, Fourrts (India) Laboratories + Mr Sachin Sundar. needs to invest more in R&D.